Marketing-authorisation holder · Romania
B. Braun Pharmaceuticals S.A.
257 medicines in 2 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Romania
257 medicines in 2 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 257
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| ACETATED RINGER'S IN PLASTIC CONTAINER20mg/100ml; 30mg/100ml; 380mg/100ml; 600mg/100ml · Injectable | Calcium chloride, Potassium chloride, Sodium acetate, Sodium chloride | United States | Not marketed | 1982 |
| ACETIC ACID 0.25% IN PLASTIC CONTAINER250mg/100ml · Solution | Acetic acid, Glacial | United States | Marketed | 1976 |
| ALCOHOL 5% AND DEXTROSE 5%5ml/100ml; 5gm/100ml · Injectable | Alcohol, Dextrose | United States | Not marketed | 1946 |
| AMINO ACIDS15%(150gm/1000ml) | 15%(300gm/2000ml) · Injectable | Amino acids | United States | Marketed | 2012 |
| AMMONIUM CHLORIDE 2.14%40meq/100ml · Injectable | Ammonium | United States | Not marketed | 1978 |
| BALANCED SALT0.48mg/ml; 0.3mg/ml; 0.75mg/ml; 3.9mg/ml; 6.4mg/ml; 1.7mg/ml · Solution | Calcium chloride, Magnesium chloride, Potassium chloride, Sodium acetate, Sodium chloride, Sodium citrate | United States | Marketed | 2006 |
| CEFAZOLIN AND DEXTROSE1gm base/vial | 2gm base/vial | 3gm base/vial | 500mg base/vial · Injectable | Cefazolin | United States | Marketed | 2000 |
| CEFEPIME AND DEXTROSE IN DUPLEX CONTAINER1gm base/vial | 2gm base/vial · Injectable | Cefepime | United States | Marketed | 2010 |
| CEFOTAXIME AND DEXTROSE 2.4% IN PLASTIC CONTAINER2gm base · Injectable | Cefotaxime | United States | Not marketed | 2004 |
| CEFOTAXIME AND DEXTROSE 3.9% IN PLASTIC CONTAINER1gm base · Injectable | Cefotaxime | United States | Not marketed | 2004 |
| CEFOTETAN AND DEXTROSE IN DUPLEX CONTAINER1gm base/vial | 2gm base/vial · Injectable | Cefotetan | United States | Not marketed | 2007 |
| CEFOXITIN AND DEXTROSE IN DUPLEX CONTAINER1gm base/vial | 2gm base/vial · Injectable | Cefoxitin | United States | Marketed | 2006 |
| CEFTAZIDIME IN DEXTROSE CONTAINER1gm base | 2gm base · Injectable | Ceftazidime | United States | Not marketed | 2011 |
| CEFTRIAXONE AND DEXTROSE IN DUPLEX CONTAINER1gm base/vial | 2gm base/vial · Injectable | Ceftriaxone | United States | Marketed | 2005 |
| CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER1.5gm base/vial | 750mg base/vial · Injectable | Cefuroxime | United States | Not marketed | 2001 |
| DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER10gm/100ml; 110mg/100ml · Injectable | Dextrose, Sodium chloride | United States | Marketed | 1988 |
| DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER10gm/100ml; 200mg/100ml · Injectable | Dextrose, Sodium chloride | United States | Marketed | 1980 |
| DEXTROSE 10% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER10gm/100ml; 330mg/100ml · Injectable | Dextrose, Sodium chloride | United States | Marketed | 1988 |
| DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER10gm/100ml; 450mg/100ml · Injectable | Dextrose, Sodium chloride | United States | Marketed | 1979 |
| DEXTROSE 2.5% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER2.5gm/100ml; 110mg/100ml · Injectable | Dextrose, Sodium chloride | United States | Marketed | 1988 |
| DEXTROSE 2.5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINER2.5gm/100ml; 200mg/100ml · Injectable | Dextrose, Sodium chloride | United States | Marketed | 1988 |
| DEXTROSE 2.5% AND SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINER2.5gm/100ml; 330mg/100ml · Injectable | Dextrose, Sodium chloride | United States | Marketed | 1988 |
| DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER2.5gm/100ml; 900mg/100ml · Injectable | Dextrose, Sodium chloride | United States | Marketed | 1980 |
| DEXTROSE 2.5% IN HALF-STRENGTH LACTATED RINGER'S IN PLASTIC CONTAINER10mg/100ml; 2.5gm/100ml; 15mg/100ml; 300mg/100ml; 160mg/100ml · Injectable | Calcium chloride, Dextrose, Potassium chloride, Sodium chloride, Sodium lactate | United States | Marketed | 1988 |
| DEXTROSE 2.5% IN PLASTIC CONTAINER2.5gm/100ml · Injectable | Dextrose | United States | Not marketed | 1980 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| United States | 189 | 189 | 0 | CompaniesAll medicines |
| Saudi Arabia | 68 | 68 | 0 | CompaniesAll medicines |
Also in the registers of Croatia
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: U.S. FDA, Drugs@FDA / openFDA. FDA does not endorse this site.
Licence: Public domain (U.S. Government work)
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Saudi Food and Drug Authority (SFDA), foreign human medicine open-data listing, source scope 2023, retrieved 11 October 2026 UTC; exact original file and response modification date retained.
Licence: Exact SFDA open-data section explicitly offers freely usable named human medicine workbooks; factual-data scope only
Report an error or request removalCorrections from the company itself are welcome.
Other companies in the same group.
Ranked by their number of medicines.